TNF profiles in ovarian cancer and their response to anticancer therapy

被引:0
|
作者
Volodko, N [1 ]
Oleksyak, O [1 ]
Barylka, V [1 ]
Piddubnyak, V [1 ]
Bilynsky, B [1 ]
机构
[1] Med Univ, Dept Oncol & Medradiol, Lviv, Ukraine
关键词
D O I
10.1016/S0959-8049(99)81388-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
968
引用
收藏
页码:S244 / S245
页数:2
相关论文
共 50 条
  • [31] Stroma cells modulate growth and response to therapy in ovarian cancer cells
    Liu, J.
    Yao, M.
    Kryczck, I.
    Kuick, R.
    Fogoros, S.
    Opipari, A.
    Kwok, R.
    Bowtell, D. D.
    Zou, W.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S153 - S153
  • [32] Measurement of the idiotypic network response to monoclonal antibody therapy for ovarian cancer
    Nicholson, S
    George, AJT
    Thomas, H
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S38 - S38
  • [33] DNA methylation alterations in ovarian cancer: impact on cancer initiation, progression and response to therapy
    Bachvarov, Dimcho
    Keita, Mamadou
    Wang, Zhi-Qiang
    Pelletier, Jean-Francois
    Bachvarova, Magdalena
    Plante, Marie
    Gregoire, Jean
    Renaud, Marie-Claude
    Mes-Masson, Anne-Marie
    Paquet, Eric R.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 : S40 - S40
  • [34] DNA methylation alterations in ovarian cancer: impact on cancer initiation, progression and response to therapy
    Keita, M.
    Wang, Z. -Q.
    Pelletier, J. -F.
    Bachvarova, M.
    Plante, M.
    Gregoire, J.
    Renaud, M. -C.
    Sebastianelli, A.
    Mes-Masson, A. -M.
    Bachvarov, D.
    FEBS JOURNAL, 2014, 281 : 300 - 300
  • [35] Gut microbiota and its influence on ovarian cancer carcinogenesis, anticancer therapy and surgical treatment: A literature review
    Giudice, Elena
    Salutari, Vanda
    Ricci, Caterina
    Nero, Camilla
    Carbone, Maria Vittoria
    Ghizzoni, Viola
    Musacchio, Lucia
    Landolfo, Chiara
    Perri, Maria Teresa
    Camarda, Floriana
    Scambia, Giovanni
    Lorusso, Domenica
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 168
  • [36] Identification of chromene based anticancer agents for ovarian cancer
    Kulshrestha, Arpita
    Beaman, Kenneth
    Patil, Shivaputra
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [37] BRMS1: Metastasis suppressor gene methylation as a target for anticancer therapy in breast and ovarian cancer
    Zhang, Shu
    Balch, Curtis
    Fan, Meiyun
    Nephew, Kenneth P.
    CANCER RESEARCH, 2006, 66 (08)
  • [38] INSIGHT THE ANTICANCER ACTIVITY OF CANNABINOIDS IN OVARIAN CANCER CELLS
    Fraguas Sanchez, A. I.
    Satta, A.
    Cacchietti, F.
    Fernandez-Carballido, A.
    Figini, M.
    Torres-Suarez, A. I.
    Mezzanzanica, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 694 - 694
  • [39] Photodynamic Therapy Enhanced Anticancer Efficacy of Cervical Cancer Through Immune Response Stimulation
    Gao, Qiaoling
    Li, Caihong
    Huang, Zhisheng
    Zhang, Xiaolong
    Luo, Youzhen
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2020, 10 (06) : 749 - 756
  • [40] Methylation profiles of hereditary and sporadic ovarian cancer
    Bol, Guus M.
    Suijkerbuijk, Karijn P. M.
    Bart, Joost
    Vooijs, Marc
    van der Wall, Elsken
    van Diest, Paul J.
    HISTOPATHOLOGY, 2010, 57 (03) : 363 - 370